Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2008
12/04/2008WO2007092772A3 Protein formulations
12/04/2008WO2007092496A3 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
12/04/2008WO2007089862A3 Alpha-synuclein kinase
12/04/2008WO2006124269A3 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300181 Methods of using IL-1 antagonists to treat neointimal hyperplasia
12/04/2008US20080299618 Single domain ligands, receptors comprising said ligands, methods for their production and use of said ligands and receptors
12/04/2008US20080299591 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
12/04/2008US20080299547 Novel stra6 polypeptides
12/04/2008US20080299153 B. anthracis prevention and treatment: mutant b. anthracis lacking luxs activity and furanone inhibition of growth, ai-2 quorum sensing, and toxin production
12/04/2008US20080299152 Norovirus Vaccine Formulations
12/04/2008US20080299151 Influenza vaccines
12/04/2008US20080299150 Method and system for processing immuno-competent cells in view of an antiviral therapy, and related therapeutic process
12/04/2008US20080299149 Raccoon Poxvirus Expressing Genes of Feline Antigens
12/04/2008US20080299148 Novel antitoxin and vaccine platform based on nodavirus VLPS
12/04/2008US20080299143 Cryptosporidium parvum antigens, antibodies thereof and diagnostic and therapeutic compositions thereof
12/04/2008US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection
12/04/2008US20080299141 Raccoon Poxvirus Expressing Genes of Porcine Virus
12/04/2008US20080299140 Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv Condition
12/04/2008US20080299139 Mammalian cytokines; related reagents and methods
12/04/2008US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof
12/04/2008US20080299137 Fusion Proteins That Bind Effector Lymphocytes And Target Cells
12/04/2008US20080299136 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
12/04/2008US20080299135 Methods and compositions for nerve regeneration
12/04/2008US20080299134 Recombinant Anti-Interleukin-9 Antibodies
12/04/2008US20080299133 Anti-Il-12 Antibody Based Vectors, Host Cells, and Methods of Production and Uses
12/04/2008US20080299132 Synergistic compositions for treating HIV-1
12/04/2008US20080299131 Anti-Viral Compositions
12/04/2008US20080299130 Methods And Compositions For The Treatment Of Ocular Neovascularization
12/04/2008US20080299129 Antagonists to il-17a, il-17f, and il-23p19 and methods of use
12/04/2008US20080299128 prevent immune cells from binding to other cells by contacting the immune cells and the other cells with a composition with bone marrow stromal cell antigen 2 (Bst2) antagonist; antiinflamatory agents
12/04/2008US20080299127 Protective staphylococcus aureus vaccine based on cell wall-associated proteins
12/04/2008US20080299126 Having high affinity and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof; useful for increasing muscle mass, increasing bone density, or for the treatment of various disorders in mammalian and avian species
12/04/2008US20080299125 Genetic basis of treatment response in depression patients
12/04/2008US20080299124 Novel method for the stabilization of chimeric immunoglobulin or immunoglobulin fragments and, and stabilized anti-egp-2 scfv fragment
12/04/2008US20080299123 Treatment of chemotherapy- or radiotherapy-resistant tumors
12/04/2008US20080299122 Modulating immune responses
12/04/2008US20080299121 Multivalent recombinant antibodies for treating HRV infections
12/04/2008US20080299120 Multivalent antibodies and uses therefor
12/04/2008US20080299119 Polypeptides homologous to vegf and bmp1
12/04/2008US20080299118 FXR Agonists for the Treatment of Malignancies
12/04/2008US20080299117 Treatment Method
12/04/2008US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof
12/04/2008US20080299115 Antibody Variants with Faster Antigen Association Rates
12/04/2008US20080299114 Humaneered anti-factor b antibody
12/04/2008US20080299113 Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
12/04/2008US20080299112 Human Polyclonal Antibodies from Genetically Engineered Animals
12/04/2008US20080299111 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
12/04/2008US20080299110 diagnosing and/or for the prognosis of non-autoimmune acute joint inflammation by detecting cytokine biomarkers; detecting IL-6, MCP-1, MIP-1 beta , or IFN gamma in synovial fluid
12/04/2008US20080299108 Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue
12/04/2008US20080299084 Bacterially derived intact minicells that encompass plasma free functional nucleic acid for in vivo delivery to mammalian cells
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008US20080299078 Tumor associated amino acids and uses therefor
12/04/2008US20080299076 Compunds and compositions that cause non-apoptotic cell death and uses thereof
12/04/2008US20080299074 A-beta immunogenic peptide carrier conjugates and methods of producing same
12/04/2008US20080299073 Method For Treatment Or Prophylaxis Of An Infection Using Either An Antibody Which Binds To IL-9 Or An Agent Which Stimulates Production Of Autoantibodies To Interleukin-9
12/04/2008US20080299042 Membrane Associated Molecules
12/04/2008US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier
12/04/2008DE102007025291A1 Verfahren und Immunabsorbentien zur spezifischen Detektion und Absorption Zöliakie- und Dermatitis herpetiformis assoziierter Antikörper Procedures and immunoabsorbents for the specific detection and absorption celiac disease and dermatitis herpetiformis associated antibodies
12/04/2008CA2693819A1 Hematopoietic cells that express mosc-1
12/04/2008CA2692652A1 Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines
12/04/2008CA2689895A1 Non-glycosylated recombinant monovalent antibodies
12/04/2008CA2689664A1 Cancer treatment combination therapy comprising vinflunine and trastuzumab
12/04/2008CA2689260A1 Vaccine peptide combinations against cat allergy
12/04/2008CA2688587A1 Nucleic acid and amino acid sequences, and vaccine to control sea lice infestations in fish
12/04/2008CA2688346A1 Compositions and methods for enhancing immune responses to vaccines
12/04/2008CA2688344A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008CA2688284A1 Streptococcus pneumoniae pilus antigens
12/04/2008CA2688275A1 Stable igg4 antibodies
12/04/2008CA2688194A1 Antiviral drugs for treatment or prevention of dengue infection
12/04/2008CA2687728A1 Mutated parvovirus structural proteins as vaccines
12/04/2008CA2687586A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008CA2687583A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008CA2687575A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity
12/04/2008CA2687499A1 New indications for anti- il-i-beta therapy
12/04/2008CA2687206A1 Monoclonal antibodies against claudin-18 for treatment of cancer
12/04/2008CA2685057A1 Set of means for treating a malignant pathology, an autoimmune disease or an infectious disease
12/04/2008CA2683498A1 Prevention and treatment of complement-associated eye conditions
12/04/2008CA2678180A1 Methods and compositions for improving immune responses
12/04/2008CA2665885A1 Treatment and prevention of chronic asthma using antagonists of integrin .alpha.nu.beta.6
12/03/2008EP1998177A2 Compositions and methods for diagnosing and treating colon cancers
12/03/2008EP1997900A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
12/03/2008EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications
12/03/2008EP1997894A2 Biosynthetic binding protein for cancer marker
12/03/2008EP1997893A1 Compositions containing an OX-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/03/2008EP1997881A1 Tuberculosis vaccine
12/03/2008EP1997832A1 Monoclonal antibodies against Claudin-18 for treatment of cancer
12/03/2008EP1997829A1 Albumin fusion proteins
12/03/2008EP1997514A1 High avidity polyvalent and polyspecific reagents
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1997511A1 Therapeutic agent for rheumatoid arthritis
12/03/2008EP1997481A1 Solid oral form of a medicinal preparation and a method for the production thereof
12/03/2008EP1996716A2 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
12/03/2008EP1996715A1 Bacterial antigens and uses thereof
12/03/2008EP1996711A2 Novel plant virus particles and methods of inactivation thereof
12/03/2008EP1996701A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2
12/03/2008EP1996700A1 Cancerous disease modifying antibody 141205-05
12/03/2008EP1996699A1 Cancerous disease modifying antibodies
12/03/2008EP1996626A1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
12/03/2008EP1996625A1 Anti-tat226 antibodies and immunoconjugates
1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 1823